| Title | EMBO Molecular Medicine |
| Abbreviation | EMBO Mol. Med. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Medicine (Q1) |
| h-index | 130 |
| Overall Rank/Ranking | 389 |
| SCImago Journal Rank (SJR) | 3.932 |
| Impact Score | 9.42 |
| Publisher | Wiley-Blackwell |
| Country | United Kingdom |
| ISSN | 17574676, 17574684 |
| Best Quartile | Q1 |
| Coverage History | 2009-2022 |
EMBO Molecular Medicine is a journal covering the technologies/fields/categories related to Molecular Medicine (Q1). It is published by Wiley-Blackwell. The overall rank of EMBO Molecular Medicine is 389. According to SCImago Journal Rank (SJR), this journal is ranked 3.932. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 130. The best quartile for this journal is Q1.
The ISSN of EMBO Molecular Medicine journal is 17574676, 17574684. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. EMBO Molecular Medicine is cited by a total of 4154 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of EMBO Molecular Medicine is 9.42, which is computed in 2023 as per its definition. EMBO Molecular Medicine IF is decreased by a factor of 1.26 and approximate percentage change is -11.8% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of EMBO Molecular Medicine is 9.42. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.42 |
| 2021 | 10.68 |
| 2020 | 8.86 |
| 2019 | 7.43 |
| 2018 | 9.15 |
| 2017 | 9.27 |
| 2016 | 8.35 |
| 2015 | 8.82 |
| 2014 | 7.77 |
EMBO Molecular Medicine has an h-index of 130. It means 130 articles of this journal have more than 130 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of EMBO Molecular Medicine is 17574676, 17574684. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of EMBO Molecular Medicine is 389. According to SCImago Journal Rank (SJR), this journal is ranked 3.932. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.932 |
| 2021 | 4.039 |
| 2020 | 4.923 |
| 2019 | 4.816 |
| 2018 | 5.033 |
| 2017 | 5.440 |
| 2016 | 5.138 |
| 2015 | 5.642 |
| 2014 | 4.934 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 389 |
| 2021 | 379 |
| 2020 | 298 |
| 2019 | 295 |
| 2018 | 287 |
| 2017 | 256 |
| 2016 | 268 |
| 2015 | 228 |
| 2014 | 295 |
EMBO Molecular Medicine is published by Wiley-Blackwell. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2009-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of EMBO Molecular Medicine is EMBO Mol. Med.. This abbreviation ('EMBO Mol. Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
EMBO Molecular Medicine latest impact IF is 9.42. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 10.68 (2021) and 7.43 (2019), respectively, in the last 9 years. Moreover, its average IS is 8.86 in the previous 9 years.
The EMBO Molecular Medicine has an SJR (SCImago Journal Rank) of 3.932, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 5.642 in 2015 and the lowest being 3.932 in 2022. Furthermore, the average SJR of the EMBO Molecular Medicine over the previous 9-year period stands at 8.86.
The latest h-index of the EMBO Molecular Medicine is 130.
The EMBO Molecular Medicine is published by the Wiley-Blackwell, with its country of publication being the United Kingdom.
The EMBO Molecular Medicine is currently ranked 389 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 228 in 2015 and its lowest position of 389 in 2022.
The standard ISO4 abbreviation for the EMBO Molecular Medicine is EMBO Mol. Med..
EMBO Molecular Medicine is classified as a journal that the Wiley-Blackwell publishes.
The EMBO Molecular Medicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The EMBO Molecular Medicine is assigned the following International Standard Serial Numbers (ISSN): 17574676, 17574684.
The best quartile for the EMBO Molecular Medicine is Q1 (2022).
The EMBO Molecular Medicine coverage history can be summarized as follows: 2009-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Journal of International Financial Management and Accounting | journal | 6179 | Wiley-Blackwell Publishing Ltd | 42 | 6.09 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| International Journal of Mathematical Education in Science and Technology | journal | 10040 | Taylor and Francis Ltd. | 39 | 1.33 |
| Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
| European Journal of Wildlife Research | journal | 8709 | Springer Verlag | 56 | 1.99 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.42 |
| 2021 | 10.68 |
| 2020 | 8.86 |
| 2019 | 7.43 |
| 2018 | 9.15 |
| 2017 | 9.27 |
| 2016 | 8.35 |
| 2015 | 8.82 |
| 2014 | 7.77 |
